PLUS1
29.85
0.00 (0.0%)
0.00 (0.0%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Level 1 Starter
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Avanos Medical Inc | AVNS | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Low Price | High Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 1.18 | 4.12% | 29.85 | 28.5387 | 29.87 | 28.90 | 28.67 | 20:00:00 |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 3,413 | 227,210 | $ 29.58 | $ 6,720,352 | 330,179 | 19.46 - 48.07 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:00:00 | 34,978 | $ 29.85 | USD |
Avanos Medical Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 1.43B | 47.76M | 41.63M | $ 697.60M | $ -17.93M | -0.96 | -79.51 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 2.27M | $ - | 0.00% | 212.67k | 1.30% |
Avanos Medical News
| Date | Time | Source | News Article |
|---|---|---|---|
| 7/02/2020 | 09:00 | GlobeNewswire Inc. | MiMedx Announces Concurrent $150 Million Private Equity and.. |
| 5/28/2020 | 07:00 | PR Newswire (US) | Avanos Medical, Inc. to Present at Two Virtual Investor.. |
| 5/27/2020 | 12:58 | Edgar (US Regulatory) | Specialized Disclosure Report (sd) |
| 5/11/2020 | 18:21 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 5/11/2020 | 18:19 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 5/11/2020 | 18:17 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 5/11/2020 | 18:15 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical AVNS Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 31.02 | 31.09 | 28.10 | 29.46 | 272,158 | -1.17 | -3.77% |
| 1 Month | 29.36 | 31.16 | 27.09 | 29.13 | 307,002 | 0.49 | 1.67% |
| 3 Months | 30.18 | 34.53 | 24.7094 | 29.43 | 362,847 | -0.33 | -1.09% |
| 6 Months | 33.08 | 35.1826 | 19.46 | 28.90 | 400,608 | -3.23 | -9.76% |
| 1 Year | 43.58 | 48.07 | 19.46 | 32.50 | 370,957 | -13.73 | -31.51% |
| 3 Years | 63.67 | 72.96 | 19.46 | 40.73 | 347,339 | -33.82 | -53.12% |
| 5 Years | 63.67 | 72.96 | 19.46 | 40.73 | 347,339 | -33.82 | -53.12% |
Avanos Medical Description
| Avanos Medical Inc is a United States-based company that develops and sells medical devices and related services globally. The firm operates in one segment, medical devices, which primarily sells products related to pain management, IV Therapy, and respiratory and digestive health. The company divides its Medical Devices segment into two franchises: Pain Management and Chronic Care. Pain Management provides non-opioid products for acute and interventional pain, including cold and compression therapy. Chronic Care aims at addressing digestive and respiratory issues with feeding tubes and catheters. Avanos generates most of its revenue from its Chronic Care franchise and in North America. |
